Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2020-06-24
2024-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* take about 3-4 hours of your time per week over 3-5 weeks.
* be conducted remotely by phone, video call, email, and mail.
* require a smart phone to answer 5 quick surveys a day
* you will need to answer 4 weekly surveys
* take part in a weekly video or phone call with research staff
* supply three saliva samples to be later tested for nicotine and other toxicants
* and use a device to measure your carbon monoxide levels four times a day.
You will be compensated for your time.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Addictive Potential of LCCs in Dual Users
NCT03496077
Effects of Cigar Flavors on Measures of Abuse Liability Among Young Adults
NCT02937051
Manipulating Tobacco Constituents in Male Menthol Smokers
NCT02592772
The Effect of Sweet Flavoring on the Rewarding and Reinforcing Value of Cigarillo Use Among Young Adults
NCT05092919
Responses of Adults Smoking Nondaily and Daily in the Experimental Tobacco Marketplace
NCT06988371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Flavored Filtered Cigars
Half of the group will be randomized to start with flavored filtered cigars (FCs) at the second visit and cross over to unflavored FCs at the third visit. FCs will be Cheyenne filtered cigars.
Flavored filtered cigars
Flavored and unflavored Cheyenne filtered cigars that are currently available in the marketplace for purchase
Unflavored Filtered Cigars
Half of the group will be randomized to start with unflavored FCs at the second visit and cross over to flavored FCs at the third visit. FCs will be Cheyenne filtered cigars.
Unflavored filtered cigars
Flavored and unflavored Cheyenne filtered cigars that are currently available in the marketplace for purchase
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flavored filtered cigars
Flavored and unflavored Cheyenne filtered cigars that are currently available in the marketplace for purchase
Unflavored filtered cigars
Flavored and unflavored Cheyenne filtered cigars that are currently available in the marketplace for purchase
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read, speak, and understand English
* Age 21-34 years
* Stable residence (does not intend to move during the study period)
* Not intending to quit smoking during the study period
* Has a smart phone with a data plan (this study is being done remotely)
* Saliva cotinine level \>30 ng/mL
Exclusion Criteria
* Current use of nicotine replacement products or cessation products (e.g., bupropion) or plans to use in the next 3 weeks for the purposes of cessation.
* Diagnosed with or being treated for COPD, emphysema, and/or uncontrolled asthma as determined by research screening.
* Currently taking anti-hypertensive medications
* Currently has pneumonia, bronchitis, or COVID symptoms that has not yet resolved, or was hospitalized or visited the ER in the past 4 weeks for a respiratory-related illness that has not yet resolved (can be re-screened once resolved)
* Resident of Alaska, Hawaii, or Massachusetts
21 Years
34 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
UConn Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erin Mead-Morse
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erin Mead-Morse, PhD,MHS
Role: PRINCIPAL_INVESTIGATOR
UConn Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UConn Health
Farmington, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-202-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.